A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer
Clinical trial NCT00488722 · UNKNOWN
Trial details
- NCT number
- NCT00488722
- Sponsor
- Tianjin Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.